Please login to the form below

Not currently logged in
Email:
Password:

Alexza’s Peter Schineller joins Agendia

Appointed first chief commercial officer

Agendia Peter SchinellerCancer diagnostics firm Agendia has appointed Peter Schineller as its first chief commercial officer.

Schineller's appointment marks a swift departure from his previous role at Alexza Pharmaceuticals, which he only joined in March 2013 as senior VP and chief commercial officer.

He has additional healthcare experience as general manager at Roche subsidiary Ventana Medical Systems and as senior VP for sales, marketing and commercial operations at Genoptix Medical Laboratories, a diagnostic firm that was acquired by Novartis.

David Macdonald, Agendia's CEO, explained the creation of the new commercial role: "As we continue our growth momentum into 2013, we are committed to building out a world class organisation capable of managing and growing a much larger company.

"Mr Schineller's depth of experienced senior leadership of global commercial organisations will help us perpetuate our volume growth, which exceeded 140 percent in 2012."

5th June 2013

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 950 experts delivering world-class...

Latest intelligence

Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...